Mobility paves Samsung’s silver path
The Korean giant’s early bet on mobile phones helped it hit the $10-bn mark in India, but in its 25th year it ...
File photo - Bloomberg
Tata Consultancy Services (TCS) on Friday launched the Advanced Drug Development (ADD) Site Feasibility Platform, which provides life sciences companies with a single, integrated platform.
The platform digitises the site selection and activation processes, and facilitates data-driven decision-making while assessing site feasibility for multi-site clinical trials.
When planning a clinical study, the following aspects have an impact on the outcomes:
1. Selection of the right sites for the clinical trials
2. Patient population
3. Investigator profiles
4. Treatment facilities and other parametres
Yet, this critical activity was done manually, resulting in sub-optimal site choices that can result in significant delays and costs.
In a statement, TCS said that its Site Feasibility Platform addresses this critical problem currently faced by life sciences companies by leveraging the power of digital technologies to drive superior clinical outcomes.
The new platform consolidates data currently residing on multiple systems within the enterprise into a central knowledge repository from which it derives insights that can be used to identify the sites best suited for a given study protocol, with the most appropriate patient population and investigators.
It digitises and automates the entire assessment and selection process, enabling the efficient and coordinated management of hundreds of concurrent clinical trial feasibility studies.
Moreover, the platform is fully integrated with the TCS Connected Clinical Trials e-Survey Platform, providing customers with an end-to-end solution for conducting site surveys and analyzing the survey responses.
TCS said a leading life sciences company is the first customer to go live with its ADD Site Feasibility Platform.
“We are leveraging our deep knowledge of the life sciences industry to continually expand the capabilities of the TCS ADD suite of cloud platforms. The Site Feasibility platform will help our customers digitally transform the most critical study design aspects of their clinical trials and drive superior outcomes,” said Debashis Ghosh, President, Life Sciences and Healthcare, TCS.
The Korean giant’s early bet on mobile phones helped it hit the $10-bn mark in India, but in its 25th year it ...
Antrix should adopt a different tactic than merely fighting over jurisdiction: Experts
Invest in relationships, enterprise, behaviour, effort and learning
From different types of osmoses to new membranes, researchers have come up with ways of drawing water
What filters should you apply when mining for under-the-radar small-cap stocks? Read on to find more
High valuation, intensely competitive landscape and small cap nature of the stock are key risks.
Amid choppiness, the benchmark indices slipped marginally; approach the week with caution
SBI Cards (₹1,032.7): Witnesses fresh breakoutBetween September and December last year, the stock of SBI Cards ...
That weekend came the news that Champa’s elder daughter was engaged, the proof arriving in the form of Jaimini ...
“Amma,” Divya yelled from the bathroom. “There’s something in my teeth.”Balakrishnan and Veena froze and ...
What makes the new crop of young Indian cricketers such game-changing winners? Over and above their talent, ...
For their dead, Parsis practise a 3,000-year-old system where corpses are excarnated in the Tower of Silence, ...
WPP agency Wunderman Thompson has launched its annual Future 100 report, lifting the lid on trends shaping the ...
Paneer, once alien to the South, has found a lucrative market in Chennai
Social media influencers are flipping the rules by first getting followers and then launching products and ...
The Flipkart kids playing adults are back — this time to push the home grown e-commerce marketplace’s grocery ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor